You are here: Industry Insights > AAV

News List

CEVEC Expands AAV Production Platform contractpharma
April 17, 2019
Secures funding to expand commercialization of CAP GT-based stable adeno-associated viral (AAV) vector production platform...
Catalent to Acquire Paragon for $1.2B contractpharma
April 16, 2019
To provide new expertise and capabilities in fast-growing gene therapy space.
GenEdit reels in $8.5M to tackle delivery for gene therapy, gene editing fiercebiotech
December 27, 2018
In October last year, a team of UC Berkeley scientists reported a new, nonviral CRISPR-delivery system that might address safety concerns with the gene-editing technology.....
Cobra, Pall, Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant contractpharma
November 27, 2018
Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work with Cobra Biologics to investigate continuous manufacturing of adeno-asso
Grant winners to investigate continuous manufacturing for gene therapies cphi-online
November 27, 2018
Cobra Biologics has won a £1.5 million shared grant from Innovate UK, the UK’s innovation agency. Co-winners, Pall Corporation, a global leader in filtration, separation and purification
Three-way collaboration to advance gene therap cphi-online
November 14, 2018
Cobra Biologics is to collaborate with the Centre for Process Innovation (CPI), a UK-based technology innovation centre and GE Healthcare Life Sciences. The three-way partnership

Previous page 1 2 3 4 Next page